Neurotech International Ltd has released a press release.
Neurotech International: Interim Results and Capital Raising
Filed with ASX ·
6ix hasn’t read this filing yet.
Neurotech International Ltd. on 6ix
Earlier from Neurotech International
- Response to ASX Price and Volume Query
- Neurotech Proceeds to in vitro trials after Positive Results
- Response to ASX price query
- Pause in Trading
- NTI Secures Option to Cannabis Strains Targeting Autism
Later from Neurotech International
- Voluntary Suspension
- Further Success with Preliminary In-vitro Studies
- Successful Completion of In Vitro Studies
- Neurotech Expands License with Dolce Cann Global
- Quarterly Report and Appendix 4C
Follow Neurotech International into a list and get an email when it puts out news.
Follow Neurotech International